BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34515250)

  • 21. Robot-Assisted Partial Cystectomy versus Open Partial Cystectomy for Patients with Urachal Cancer.
    Stokkel LE; van de Kamp MW; Schaake EE; Boellaard TN; Hendricksen K; van Rhijn BWG; Mertens LS
    Urol Int; 2022; 106(8):840-847. PubMed ID: 35134799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary adenocarcinoma of the urinary bladder: a single site analysis of 21 cases.
    Zhang H; Jiang H; Wu Z; Fang Z; Fan J; Ding Q
    Int Urol Nephrol; 2013 Feb; 45(1):107-11. PubMed ID: 23054322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urachal Carcinoma: Are Lymphadenectomy and Umbilectomy Necessary?
    Jia Z; Chang X; Li X; Wang B; Zhang X
    Med Sci Monit; 2020 Sep; 26():e927913. PubMed ID: 32958737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy.
    Masson-Lecomte A; Vordos D; Hoznek A; Yiou R; Allory Y; Abbou CC; de la Taille A; Salomon L
    Ann Surg Oncol; 2013 Apr; 20(4):1389-94. PubMed ID: 23208127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
    Evers PD; Logan JE; Sills V; Chin AI
    World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
    Ploussard G; Shariat SF; Dragomir A; Kluth LA; Xylinas E; Masson-Lecomte A; Rieken M; Rink M; Matsumoto K; Kikuchi E; Klatte T; Boorjian SA; Lotan Y; Roghmann F; Fairey AS; Fradet Y; Black PC; Rendon R; Izawa J; Kassouf W
    Eur Urol; 2014 Aug; 66(2):361-70. PubMed ID: 24139235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer].
    Habuchi T; Kakehi Y; Terachi T; Ogawa O; Yoshida O
    Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):809-17. PubMed ID: 10565159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-tiered nodal classification system for bladder cancer: a new proposal.
    Pedrosa JA; Koch MO; Kaimakliotis HZ; Monn MF; Masterson TA; Rice KR; Cary KC; Foster RS; Bihrle R; Cheng L
    Future Oncol; 2015; 11(3):399-408. PubMed ID: 25675122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases.
    Szarvas T; Módos O; Niedworok C; Reis H; Szendröi A; Szász MA; Nyirády P
    Urol Oncol; 2016 Sep; 34(9):388-98. PubMed ID: 27267737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of treatment and prognosis in post-operative patients with urachal carcinoma].
    Niu HT; Dong P; Wang JN; Huang J; Zeng YX
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1923-5. PubMed ID: 27373362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience.
    Siefker-Radtke AO; Gee J; Shen Y; Wen S; Daliani D; Millikan RE; Pisters LL
    J Urol; 2003 Apr; 169(4):1295-8. PubMed ID: 12629346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
    Fritsche HM; May M; Denzinger S; Otto W; Siegert S; Giedl C; Giedl J; Eder F; Agaimy A; Novotny V; Wirth M; Stief C; Brookman-May S; Hofstädter F; Gierth M; Aziz A; Kocot A; Riedmiller H; Bastian PJ; Toma M; Wieland WF; Hartmann A; Burger M
    Eur Urol; 2013 Apr; 63(4):739-44. PubMed ID: 23079053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
    Bruins HM; Dorin RP; Rubino B; Miranda G; Cai J; Daneshmand S; Skinner EC
    Eur Urol; 2012 Oct; 62(4):671-6. PubMed ID: 22575915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urachal carcinoma: A novel staging system utilizing the National Cancer Database.
    Limonnik V; Samiei A; Abel S; Wegner RE; Vemana G; Mao SS
    Cancer Med; 2023 Feb; 12(3):2752-2760. PubMed ID: 36069175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.
    Raza SJ; Al-Daghmin A; Zhuo S; Mehboob Z; Wang K; Wilding G; Kauffman E; Guru KA
    Eur Urol; 2014 Nov; 66(5):920-8. PubMed ID: 24768522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urachal carcinoma: a pathologic and clinical study of 46 cases.
    Dhillon J; Liang Y; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2015 Dec; 46(12):1808-14. PubMed ID: 26364859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.
    Murakami Y; Matsumoto K; Shimizu Y; Ikeda M; Amano N; Shimura S; Ishii D; Sato Y; Iwamura M
    Urol Oncol; 2021 Mar; 39(3):195.e15-195.e23. PubMed ID: 33071109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database.
    Davaro F; Schaefer J; May A; Raza J; Siddiqui S; Hamilton Z
    World J Urol; 2019 Mar; 37(3):497-505. PubMed ID: 30030660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.